Provided herein is a substance for use in a therapeutic method for stimulating cells in the human immune system, a method for producing this substance, and a method of use of the substance for stimulating cells of the human immune system in treating various diseases involving immune system disorders.

Provided herein is a substance for use in a therapeutic method for stimulating cells in the human immune system, a method for producing this substance, and a method of use of the substance for stimulating cells of the human immune system in treating various diseases involving immune system disorders.

The present invention relates to a seaweed-based composition comprising water, a seaweed powder and an additional component, said additional component being chosen from the group consisting of glucomannans, galactomannans, native starch and combinations thereof. Preferably, the red seaweed selected from the families of Gigartinaceae, Bangiophyceae, Palmariaceae, Hypneaceae, Cystocloniaceae, Solieriaceae, Phyllophoraceae and Furcellariaceae or combinations thereof.

The invention relates to a method for enriching a biomass of a microalga of the species Tetraselmis chuii in superoxide dismutase (SOD) by placing said microalga under abiotic stress conditions. The invention also relates to a biomass enriched in SOD as well as to an extract of the microalga and to the uses thereof as a pharmaceutical composition, as a cosmetic or in foodstuff.

The invention relates to a method for enriching a biomass of a microalga of the species Tetraselmis chuii in superoxide dismutase (SOD) by placing said microalga under abiotic stress conditions. The invention also relates to a biomass enriched in SOD as well as to an extract of the microalga and to the uses thereof as a pharmaceutical composition, as a cosmetic or in foodstuff.

A method of treating vaginal dryness by administering a vaginal care composition, which includes an effective amount of a vaginal care agent, to vaginal tissue of a user experiencing vaginal dryness. The vaginal care agent may be selected to specifically treat symptoms of vaginal dryness exhibited by the introitus and/or labia, based on the transcriptomic data of skin cells obtained therefrom. In some instances, the vaginal care composition may be applied to introitus and/or labia with a suitable implement configured for such use.

A method for manufacturing a fucoidan cosmetic composition includes: washing mozuku to eliminate residual salt and impurities; adding citric acid to the washed mozuku and pulverizing the mozuku; adding water to the pulverized mozuku and performing reflux extraction to obtain a high molecular weight fucoidan; adding a neutralizing agent to the high molecular weight fucoidan for neutralization; adding diatomite to the neutralized high molecular weight fucoidan and causing a reaction for 30 minutes for deodorization; filtering the deodorized high molecular weight fucoidan to eliminate insoluble substances; adding a lactic acid bacterium to the high molecular weight fucoidan removed of the insoluble substances and causing fermentation to obtain a low molecular weight fucoidan; concentrating the purified low molecular weight fucoidan with a reduced pressure evaporator; and powdering the concentrated low molecular weight fucoidan through freeze drying.

A method for using mechanical cartridges for the extraction of highly bioavailable omega-3 containing biomass oils from algal biomass is presented. Cartridges may contain an inner bore with an inlet and outlet, and may be amenable to adjustments in pressure and temperature, thereby permitting solvent-based extraction of algal biomass in which solvent temperature, pressure, retention time and flow rate are controllable.

A method for using mechanical cartridges for the extraction of highly bioavailable omega-3 containing biomass oils from algal biomass is presented. Cartridges may contain an inner bore with an inlet and outlet, and may be amenable to adjustments in pressure and temperature, thereby permitting solvent-based extraction of algal biomass in which solvent temperature, pressure, retention time and flow rate are controllable.

The present invention provides a synergistic anti-inflammatory composition comprising one more anti-inflammatory agents such as a steroid, non-steroidal anti-inflammatory drug (NSAID) or a cannabinoid in combination with one or more sulfated polysaccharides. The invention is further directed to a method of treating inflammation and inflammatory diseases using said synergistic composition.